Considering the market trend and volatility, analysts expect a flat to negative listing at the issue price. Long-term investors are advised to continue holding them…

The board of directors has declared a second interim dividend of ₹0.75 (7.5%) per equity share of face value ₹10 each for the financial year…

Net profit for the period stood at ₹255.2 crore, which was aided by a jump in other income to ₹36 crore from ₹2 crore las…

Thyrocare Technologies Q3 Results | EBITDA surged 32.4%, while the EBITDA margin stood at 25.1% versus 23.4% in the year-ago quarter. Shares of Thyrocare Technologies…

Shares of Garden Reach Shipbuilders have declined nearly 50% from their 2024-peak of ₹2,833.

Shares of Alembic Pharmaceuticals Ltd ended at ₹924.20, down by ₹12.90 or 1.38% on the BSE.

Post Content

The market capitalisation of all listed companies on BSE declined by ₹4.63 lakh crore to Rs 419.21 lakh crore today.

The redevelopment project will take place in Lokhandwala Complex, Andheri West, Mumbai. The Gross Development Value (GDV) of the project is approximately ₹950 crore.

Ridham Desai, Managing Director & Chief Equity Strategist for India at Morgan Stanley, expects new opportunities to emerge in midcap and smallcap stocks after their…